Phase I Trial of YHI-1501

Phase I Trial of YHI-1501 in Healthy Adult Japanese Subjects

Status

Unknown

Phases

Phase 1

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCT2080223241

Enrollment

Registered

2016-06-13

Start date

2016-06-13

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult male

Interventions

investigational material(s) Generic name etc : YHI-1501 INN of investigational material : Therapeutic category code : 399 Agents affecting metabolism, n.e.c. Dosage and Administration for Investigati

Eligibility

Sex/Gender

Male

Inclusion criteria

Inclusion criteria: 1. Healthy male Japanese subjects 2. BMI of 18.5 kg/m^2 or more but less than 25.0 kg/m^2

Exclusion criteria

Exclusion criteria: 1. History of alcoholism 2. History of clinically significant drug or food allergies 3. History of surgery which affects oral drug absorption

Design outcomes

Primary

Measure	Time frame
Safety	—

Secondary

Measure	Time frame
Pharmacodynamics and pharmacokinetics	—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026